Entering edit mode
Michael Barnes
▴
80
@michael-barnes-354
Last seen 10.2 years ago
I wasn't trying to be difficult and I hope you didn't take it that
way.
Simply I am currently in need of information regarding what probe
length is best and I thought following up your comment might be a way
to
find references. Of course, Affy says 25-mers are best. And there
must
be an optimal length for the reasons you explained. However, I wonder
what is the evidence that 25-mers are best as opposed to, say 20-mers,
30-mers, 50-mers, 70-mers or anything else. Hopefully there are some
suggestions and references out there that could help me.
On a related question... Affy claims 25-mers, yet they synthesize
their oligos on the chips. We all know reactions are not perfect so
there must be some amount of synthesis failure. Does anyone have a
feel
for the percentage of complete/incomplete oligos on an affy feature?
And are the short oligos prevented from binding to your sample in some
way?
BTW: If you can find ANYTHING on the Affy site, more power to you:)
Mike
>>> "Matthew Hannah" <hannah@mpimp-golm.mpg.de> 07/22/04 03:29AM >>>
I should have said it was just a logical guess.
What I meant was that if you had 2 homologous genes, obviously it
is going to be harder to avoid homologous regions if you need to find
50bp versus 25bp? But this is refering to cross-hybridisation between
PM and related sequences, I don't know how it would affect non-
specific
binding of PM to non-complementary sequences (am I right to
distinguish
these?). I should have said 'less-' rather than non-homologous, or
just
dropped the 'non-' in the initial post. Also this would only apply
where
there were related sequences present, but then different probe-lengths
for different sequences wouldn't be ideal.
Also while we're on logic another reason to consider is that with
11-20
probesets per mRNA, for short mRNAs there is already some overlap,
this
would be worse for longer probes, making them less independent. It
would
also extend the probed region further from the 3' end from where
labelling
occurs and so efficiency may be reduced?
If you need a reference I'm sure the affy website or some of their
publications
would have something.
Sorry for any confusion.
Matt
-----Original Message-----
From: Michael Barnes [mailto:Michael.Barnes@cchmc.org]
Sent: Mittwoch, 21. Juli 2004 19:49
To: Matthew Hannah; bioconductor@stat.math.ethz.ch
Subject: Re: [BioC] GCRMA backgrounds?
What are references for this?
Mike
>>> "Matthew Hannah" <hannah@mpimp-golm.mpg.de> 07/21/04 12:45PM >>>
As for the 25mers, the obvious thing to take into account is that
as you increase in length it is more likely that non-homologous
probes will bind as it would be more difficult to find sequences
that are gene specific.
HTH,
Matt
_______________________________________________
Bioconductor mailing list
Bioconductor@stat.math.ethz.ch
https://www.stat.math.ethz.ch/mailman/listinfo/bioconductor
Hi,
I've been using GCRMA and the new speedier version (1.1)
gives different values than the older slower version (1.0).
Looking through the bioconductor mails suggests that
a few other people identified a similar problem, related to a
background not being subtracted. Hopefully people are on the case,
but this problem seems to have been around since April. I've been
plugging GCRMA to my colleagues, who are now starting to use it,
so I hope the problem can be sorted out.
On a different note, what technical limitations stop
Affymetrix going for much longer probes than 25 bases? The work
of Naef and Magnasco, and Wu and Irizarry, highlight the
limitations of Affy technology due to cross-hybridisation, when
there are only 25 bases. Pushing upwards to 50 bases will reduce CH,
but what other factors then come in?
My understanding is that the Affy SNP chips have 25 base
oligos. What is stopping these chips from also having
cross-hybridisation issues?
Best wishes,
Harry
